Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with

Ali Kabir1, Seyed-Moayed Alavian, Hussein Keyvani

  • 1Tehran Hepatitis Center, Tehran, Iran. aikabir@yahoo.com

Comparative Hepatology
|October 4, 2006
PubMed

Insights

Hepatitis C virus (HCV) genotypes 1 and 3 are most common in Iran. While intravenous drug use is a risk factor, specific genotypes showed no significant association with risk factors in this study.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Limited data exists on hepatitis C virus (HCV) genotypes and risk factors in Iran.
  • This study addresses the knowledge gap by investigating HCV genotypes and associated risk factors in Iranian patients.

Purpose of the Study:

  • To identify prevalent HCV genotypes in an Iranian patient cohort.
  • To explore potential associations between identified HCV genotypes and documented risk factors.

Main Methods:

  • Genotyping analysis was conducted on 156 patients positive for anti-HCV and HCV-RNA.
  • Patients were interviewed regarding known risk factors for HCV infection.

Main Results:

  • HCV genotypes 1 (55.8%) and 3 (28.8%) were the most prevalent.
  • Subtypes 1a (37.8%) and 3a (28.9%) were most common.
  • No statistically significant link was found between analyzed risk factors and HCV acquisition.

Conclusions:

  • HCV genotypes 1a and 3a in Iranian intravenous drug users (IVDU) are less prevalent than in Europe and the USA.
  • Despite geographical differences, a notable similarity exists in genotype patterns among IVDU in Iran, Europe, and the USA.
  • Limited international travel among participants suggests migration is unlikely to explain these patterns.
Abstract